Evidence map›Paper›PMID 27030709›Full record

ArticleMolecular pain2016

Functional and structural characterization of axonal opioid receptors as targets for analgesia.

Egle M Mambretti, Katrin Kistner, Stefanie Mayer, Dominique Massotte, Brigitte L Kieffer, Carsten Hoffmann, Peter W Reeh, Alexander Brack, Esther Asan, Heike L Rittner

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Hypoxic effects of heroin and fentanyl and their basic physiological mechanisms.American journal of physiology. Lung cellular and molecular physiology · 2024
    Review
  2. The Interplay between Chronic Pain, Opioids, and the Immune System.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2022
    Review
  3. Article
  4. Review
  5. Review
  6. Tissue Regeneration: The Dark Side of Opioids.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CFJournal of enzyme inhibition and medicinal chemistry · 2018
    Article
  11. Opioids and the immune system - friend or foe.British journal of pharmacology · 2018
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Egle M MambrettiDepartment of Anesthesiology, University Hospital of Wuerzburg, Germany Institute of Anatomy and Cell Biology, University of Wuerzburg, Germany.
Katrin KistnerInstitute of Physiology and Pathophysiology, University of Erlangen-Nuremberg, Germany.
Stefanie MayerInstitute for Pharmacology and Toxicology & Bio-Imaging Center/Rudolf-Virchow Center, University of Wuerzburg, Germany.
Dominique MassotteInstitut des Neurosciences Cellulaires et Intégratives, CNRS UPR, Strasbourg Cedex, France.
Brigitte L KiefferDouglas Research Center, Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada Institut de Génétique et de Biologie Moléculaire et Cellulaire, Université de Strasbourg, Illkirch, France.
Carsten HoffmannInstitute for Pharmacology and Toxicology & Bio-Imaging Center/Rudolf-Virchow Center, University of Wuerzburg, Germany.
Peter W ReehInstitute of Physiology and Pathophysiology, University of Erlangen-Nuremberg, Germany.
Alexander BrackDepartment of Anesthesiology, University Hospital of Wuerzburg, Germany.
Esther AsanInstitute of Anatomy and Cell Biology, University of Wuerzburg, Germany.
Heike L RittnerDepartment of Anesthesiology, University Hospital of Wuerzburg, Germany rittner_h@ukw.de.
University of Würzburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversitätsklinikum Würzburg · DEInstitut de génétique et de biologie moléculaire et cellulaire · FRInstitut des Neurosciences Cellulaires et Intégratives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOpioids are the gold standard for the treatment of acute pain despite serious side effects in the central and enteric nervous system. µ-opioid receptors (MOPs) are expressed and functional at the terminals of sensory axons, when activated by exogenous or endogenous ligands. However, the presence and function of MOP along nociceptive axons remains controversial particularly in naïve animals. Here, we characterized axonal MOPs by immunofluorescence, ultrastructural, and functional analyses. Furthermore, we evaluated hypertonic saline as a possible enhancer of opioid receptor function.

resultsComparative immunolabeling showed that, among several tested antibodies, which all provided specific MOP detection in the rat central nervous system (CNS), only one monoclonal MOP-antibody yielded specificity and reproducibility for MOP detection in the rat peripheral nervous system including the sciatic nerve. Double immunolabeling documented that MOP immunoreactivity was confined to calcitonin gene-related peptide (CGRP) positive fibers and fiber bundles. Almost identical labeling and double labeling patterns were found using mcherry-immunolabeling on sciatic nerves of mice producing a MOP-mcherry fusion protein (MOP-mcherry knock-in mice). Preembedding immunogold electron microscopy on MOP-mcherry knock-in sciatic nerves indicated presence of MOP in cytoplasm and at membranes of unmyelinated axons. Application of [D-Ala(2), N-MePhe(4), Gly-ol]-enkephalin (DAMGO) or fentanyl dose-dependently inhibited depolarization-induced CGRP release from rat sciatic nerve axons ex vivo, which was blocked by naloxone. When the lipophilic opioid fentanyl was applied perisciatically in naïve Wistar rats, mechanical nociceptive thresholds increased. Subthreshold doses of fentanyl or the hydrophilic opioid DAMGO were only effective if injected together with hypertonic saline. In vitro, using β-arrestin-2/MOP double-transfected human embryonic kidney cells, DAMGO as well as fentanyl lead to a recruitment of β-arrestin-2 to the membrane followed by a β-arrestin-2 reappearance in the cytosol and MOP internalization. Pretreatment with hypertonic saline prevented MOP internalization.

conclusionMOPs are present and functional in the axonal membrane from naïve animals. Hypertonic saline acutely decreases ligand-induced internalization of MOP and thereby might improve MOP function. Further studies should explore potential clinical applications of opioids together with enhancers for regional analgesia.

Indexed as

AnalgesiaAmygdalaAnimalsAntibodies, MonoclonalAxonsBehavior, Animalbeta-ArrestinsCalcitonin Gene-Related PeptideEndocytosisEnkephalin, Ala(2)-MePhe(4)-Gly(5)-FemaleFentanylGene Knock-In TechniquesMaleMembrane PotentialsMiceAntibodies, Monoclonalbeta-ArrestinsCalcitonin Gene-Related PeptideEnkephalin, Ala(2)-MePhe(4)-Gly(5)-FentanylPotassiumReceptors, Opioid, mucalcitonin gene-related peptideDAMGOfentanylhypertonic solutioninternalizationperipheral nerveultrastructureµ-Opioid receptor

Identifiers

PMID27030709
PMCPMC4994859
OpenAlexW2335436711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.